Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Kehr

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Acta Neuropathologica|February 14, 2015
Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's diseaseCsaba Ádori, Laura Glück, Swapnali Barde, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 21, 2013
Asymmetry of the endogenous opioid system in the human anterior cingulate: a putative molecular basis for lateralization of emotions and painHiroyuki Watanabe, Sylvia Fitting, Muhammad Z Hussain, et al.
Addiction Biology|May 24, 2016
Dopamine D<sub>4</sub> receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addictionAlicia Rivera, Belén Gago, Diana Suárez-Boomgaard, et al.
Science Advances|July 22, 2021
Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imagingCsaba Adori, Teresa Daraio, Raoul Kuiper, et al.
Molecular Psychiatry|November 14, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodentsNúria Nadal-Gratacós, Pol Puigseslloses, Laura Guzmán, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor functionEric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2021
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serineGlenn Dallérac, Xia Li, Pierre Lecouflet, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2023
Cholinergic regulation of vascular endothelial function by human ChAT<sup>+</sup> T cellsLaura Tarnawski, Vladimir S Shavva, Eric J Kort, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Acta Neuropathologica|February 14, 2015
Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's diseaseCsaba Ádori, Laura Glück, Swapnali Barde, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 21, 2013
Asymmetry of the endogenous opioid system in the human anterior cingulate: a putative molecular basis for lateralization of emotions and painHiroyuki Watanabe, Sylvia Fitting, Muhammad Z Hussain, et al.
Addiction Biology|May 24, 2016
Dopamine D<sub>4</sub> receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addictionAlicia Rivera, Belén Gago, Diana Suárez-Boomgaard, et al.
Science Advances|July 22, 2021
Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imagingCsaba Adori, Teresa Daraio, Raoul Kuiper, et al.
Molecular Psychiatry|November 14, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodentsNúria Nadal-Gratacós, Pol Puigseslloses, Laura Guzmán, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor functionEric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2021
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serineGlenn Dallérac, Xia Li, Pierre Lecouflet, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2023
Cholinergic regulation of vascular endothelial function by human ChAT<sup>+</sup> T cellsLaura Tarnawski, Vladimir S Shavva, Eric J Kort, et al.
Pageof 8